ACKRELL SPAC PARTNERS I CO (ACKIU)

US00461L2043

10.36  -0.02 (-0.19%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to ACKIU. ACKIU was compared to 0 industry peers in the Unkown industry. The financial health of ACKIU is average, but there are quite some concerns on its profitability. ACKIU does not seem to be growing, but still is valued expensively.



Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year ACKIU has reported negative net income.

1.2 Ratios

Industry RankSector Rank
ROA -3.33%
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for ACKIU so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

More info and screens

4

2. Health

2.1 Basic Checks

ACKIU does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for ACKIU remains at a similar level compared to 1 year ago.
ACKIU has a worse debt/assets ratio than last year.

2.2 Solvency

ACKIU has an Altman-Z score of 22.04. This indicates that ACKIU is financially healthy and has little risk of bankruptcy at the moment.
ACKIU has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 22.04
ROIC/WACCN/A
WACC9.09%

2.3 Liquidity

A Current Ratio of 0.05 indicates that ACKIU may have some problems paying its short term obligations.
A Quick Ratio of 0.05 indicates that ACKIU may have some problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 0.05
Quick Ratio 0.05

More info and screens

1

3. Growth

3.1 Past

ACKIU shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -369.70%.
EPS 1Y (TTM)-369.7%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q4.58%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Revenue growth Q2QN/A

3.2 Future

The Earnings Per Share is expected to grow by 129.92% on average over the next years. This is a very strong growth
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y787.21%
EPS Next 2Y286.82%
EPS Next 3Y184.09%
EPS Next 5Y129.92%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

ACKIU reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
With a Price/Forward Earnings ratio of 12.12, ACKIU is valued correctly.
Compared to an average S&P500 Price/Forward Earnings ratio of 20.72, ACKIU is valued a bit cheaper.
Industry RankSector Rank
PE N/A
Fwd PE 12.12

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

ACKIU's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as ACKIU's earnings are expected to grow with 184.09% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y286.82%
EPS Next 3Y184.09%

More info and screens

0

5. Dividend

5.1 Amount

ACKIU does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ACKRELL SPAC PARTNERS I CO

NASDAQ:ACKIU (8/31/2022, 3:01:07 PM)

10.36

-0.02 (-0.19%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap197.32M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 12.12
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -3.33%
ROE N/A
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM N/A
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 0.05
Quick Ratio 0.05
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-369.7%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y787.21%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y